Live
- Lok Sabha Polls: Polling in 93 seats today
- Sathya Kumar making an indelible impression on voters
- Creating Markapuram district will boost development: TDP
- NEET UG paper leak reports baseless
- 12 Hours, 6 Machines, Rs 30 Crore: Huge cash haul in raids linked to minister
- Shah Fake Video Case: Another notice to Cong leaders
- INDIA bloc is only opposition in state, says Sharmila
- Don’t fall prey to TDP tactics, warns YSRCP
- Student stabbed to death by fellow Indian in Australia
- Nadda’s call to defeat Ram-virodhi Congress
Dexamethasone results welcomed
The World Health Organization (WHO) welcomed the positive results of dexamethasone in treating the novel coronavirus, while warning that the drug should not be used on mild cases or for prevention purposes
Geneva: The World Health Organization (WHO) welcomed the positive results of dexamethasone in treating the novel coronavirus, while warning that the drug should not be used on mild cases or for prevention purposes.
At a virtual press briefing on Wednesday, WHO Director-General Tedros Adhanom Ghebreyesus congratulated the initial results from the RECOVERY trial in the UK, which shows that dexamethasone, a common steroid, has had a beneficial effect on patients severely ill with COVID-19, reports Xinhua news agency.
For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings received by WHO.
"This is very welcome news for those patients with severe illness," said Tedros, adding: "However, dexamethasone was shown to not have a beneficial effect for those with milder disease, who did not need respiratory support."
